🔗 Permalink

Inventor profile of:

Herren Wu

City:

Boyds, Maryland

Country:

United States

Published Applications:

Last publication date:

2025-03-27

Top Assignees for applications by Herren Wu

The entities that hold a legal rights for patent applications filed by inventor Wu Herren:

MEDIMMUNE, LLC 40 Gaithersburg, MD United States
MEDIMMUNE, INC. 19 Gaithersburg, MD United States
Genentech, Inc. 5 South San Francisco, CA United States
TANOX, INC. 4 Houston, TX United States
Medlmmune, LLC 3 Gaithersburg, MD United States
Medlmmune, Inc 2 Gaithersburg, MD United States
Seattle Genetics, Inc. 2 Bothell, WA United States
AstraZeneca AB 2 Sodertalje, Sweden
Applied Molecular Evolution, Inc. 1 San Diego, CA United States
Critical Therapeutics, Inc. 1 Lexington, MA United States
YALE UNIVERSITY 1 New Haven, CT United States
The Feinstein Institute For Medical Research 1 Manhasset, NY United States
Medlmmune Way 1 Gaithersburg, MD United States
MedImmune Limited 1 Cambridge, United Kingdom
CRITICAL THERAPEUTICS 1 LEXINGTON, MA United States

Recent patent applications by Wu Herren

Herren Wu from Boyds, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-27

US20250101116A1

Chemistry; metallurgy

ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY

#2 | 2024-12-19

US20240417460A1

Chemistry; metallurgy

HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE

#3 | 2021-03-04

US20210061906A1

Chemistry; metallurgy

HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE

#4 | 2020-06-04

US20200172625A1

Chemistry; metallurgy

ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY

#5 | 2020-02-20

US20200055944A1

Chemistry; metallurgy

ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY

#6 | 2018-08-30

US20180244791A1

Chemistry; metallurgy

Anti-IFNAR1 antibodies with reduced Fc ligand affinity

#7 | 2018-05-03

US20180118839A1

Chemistry; metallurgy

Anti-IFNAR1 antibodies with reduced Fc ligand affinity

#8 | 2017-06-15

US20170166630A1

Chemistry; metallurgy

HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF

#9 | 2016-01-07

US20160002353A1

Chemistry; metallurgy

Humanized Anti-Factor D Antibodies And Uses Thereof

#10 | 2016-01-07

US20160002352A1

Chemistry; metallurgy

Humanized Anti-Factor D Antibodies And Uses Thereof

#11 | 2015-12-31

US20150376295A1

Chemistry; metallurgy

Humanized Anti-Factor D Antibodies And Uses Thereof

#12 | 2014-10-09

US20140303355A1

Chemistry; metallurgy

Humanized Anti-Factor D Antibodies And Uses Thereof

#13 | 2014-10-02

US20140295494A1

Chemistry; metallurgy

High affinity, anti-human IgE antibodies

#14 | 2013-07-04

US20130171070A1

Chemistry; metallurgy

Methods of detecting factor D with anti-factor D antibodies

#15 | 2013-05-09

US20130115657A1

Chemistry; metallurgy

Humanized anti-CD19 antibodies

#16 | 2013-02-28

US20130052202A1

Chemistry; metallurgy

High affinity, anti-human IgE antibodies

#17 | 2012-09-13

US20120230985A1

Chemistry; metallurgy

Humanized anti-factor D antibodies and uses thereof

#18 | 2012-06-07

US20120141463A1

Physics

Method of identifying membrane Ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells

#19 | 2012-05-31

US20120135006A1

Chemistry; metallurgy

ULTRA HIGH AFFINITY NEUTRALIZING ANTIBODIES

#20 | 2012-05-03

US20120109097A1

Chemistry; metallurgy

Recombinant IL-9 antibodies and uses thereof

#21 | 2012-03-22

US20120070447A1

Chemistry; metallurgy

METHODS OF ADMINISTERING / DOSING ANTI-RSV ANTIBODIES FOR PROPHYLAXIS AND TREATMENT

#22 | 2012-02-23

US20120046450A1

Chemistry; metallurgy

Modulation of antibody effector function by hinge domain engineering

#23 | 2011-11-24

US20110288276A1

Chemistry; metallurgy

Crystals and structure of a human IgG Fc variant with enhanced FcRn binding

#24 | 2011-11-24

US20110287023A1

Chemistry; metallurgy

High affinity antibodies against HMGB1 and methods of use thereof

#25 | 2011-11-17

US20110280892A1

Chemistry; metallurgy

TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES

#26 | 2011-07-07

US20110165622A1

Chemistry; metallurgy

Nucleic acids encoding anti-factor D antibodies

#27 | 2011-06-30

US20110158985A1

Chemistry; metallurgy

METHODS OF PREVENTING AND TREATING RSV INFECTIONS AND RELATED CONDITIONS

#28 | 2011-05-26

US20110123528A1

Chemistry; metallurgy

Methods of treating with anti-factor D antibodies

#29 | 2011-04-21

US20110091992A1

Chemistry; metallurgy

CRYSTALS AND STRUCTURE OF HUMAN IgG Fc VARIANT

#30 | 2011-03-31

US20110077383A1

Chemistry; metallurgy

HINGE DOMAIN ENGINEERING

#31 | 2011-03-31

US20110076752A1

Chemistry; metallurgy

ANTIBODY LIBRARY DISPLAY BY YEAST CELL PLASMA MEMBRANE

#32 | 2011-03-17

US20110064725A1

Chemistry; metallurgy

High affinity, anti-human IgE antibodies

#33 | 2011-03-10

US20110059100A1

Chemistry; metallurgy

C/CLP Antagonists And Methods Of Use Thereof

#34 | 2011-03-10

US20110059078A1

Chemistry; metallurgy

ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY

#35 | 2011-02-24

US20110044998A1

Chemistry; metallurgy

Stabilized angiopoietin-2 antibodies and uses thereof

#36 | 2011-02-10

US20110033378A1

Chemistry; metallurgy

Cysteine Engineered Antibodies For Site-Specific Conjugation

#37 | 2011-01-13

US20110008329A1

Chemistry; metallurgy

Methods of Treating RSV Infections And Related Conditions

#38 | 2010-12-30

US20100331208A1

Chemistry; metallurgy

Mutant antibody Fc domains and fusion proteins thereof

#39 | 2010-11-25

US20100298541A1

Physics

Protein scaffolds

#40 | 2010-10-21

US20100266614A1

Chemistry; metallurgy

ULTRA HIGH AFFINITY NEUTRALIZING ANTIBODIES

#41 | 2010-09-23

US20100239574A1

Chemistry; metallurgy

High potency recombinant antibodies and method for producing them

#42 | 2010-09-16

US20100233173A1

Chemistry; metallurgy

MULTISPECIFIC EPITOPE BINDING PROTEINS AND USES THEREOF

#43 | 2010-08-26

US20100216975A1

Chemistry; metallurgy

Framework-Shuffling Of Antibodies

#44 | 2010-08-12

US20100203045A1

Physics

EPH RECEPTOR Fc VARIANTS WITH ENHANCED ANTIBODY DEPENDENT CELL-MEDIATED CYTOTOXICITY ACTIVITY

#45 | 2010-07-01

US20100166746A1

Chemistry; metallurgy

HIGH POTENCY RECOMBINANT ANTIBODIES, METHODS FOR PRODUCING THEM AND USE IN CANCER THERAPY

#46 | 2010-06-10

US20100145028A1

Chemistry; metallurgy

Increasing The Production Of Recombinant Antibodies In Mammalian Cells By Site-Directed Mutagenesis

#47 | 2010-06-10

US20100143254A1

Chemistry; metallurgy

MOLECULES WITH REDUCED HALF-LIVES, COMPOSITIONS AND USES THEREOF

#48 | 2010-04-29

US20100105873A1

Chemistry; metallurgy

Integrated approach for generating multidomain protein therapeutics

#49 | 2010-04-22

US20100098708A1

Chemistry; metallurgy

METHODS OF PREVENTING AND TREATING RSV INFECTIONS AND RELATED CONDITIONS

#50 | 2010-03-11

US20100061987A1

Chemistry; metallurgy

High affinity antibodies against HMGB1 and methods of use thereof

#51 | 2010-02-04

US20100028948A1

Chemistry; metallurgy

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

#52 | 2009-12-10

US20090304721A1

Chemistry; metallurgy

TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES

#53 | 2009-12-03

US20090297514A1

Chemistry; metallurgy

HUMANIZATION OF ANTIBODIES

#54 | 2009-09-03

US20090221803A1

Chemistry; metallurgy

Modulation of antibody effector function by hinge domain engineering

#55 | 2009-09-03

US20090220527A1

Chemistry; metallurgy

AFFINITY OPTIMIZED EPHA2 AGONISTIC ANTIBODIES AND METHODS OF USE THEREOF

#56 | 2009-07-02

US20090169546A1

Chemistry; metallurgy

High affinity antibodies against HMGB1 and methods of use thereof

#57 | 2009-06-18

US20090155275A1

Chemistry; metallurgy

MULTISPECIFIC EPITOPE BINDING PROTEINS AND USES THEREOF

#58 | 2009-05-21

US20090130111A1

Physics

Method of identifying membrane IgE specific antibodies and use thereof for targeting IgE producing precursor cells

#59 | 2009-02-19

US20090047277A1

Chemistry; metallurgy

RECOMBINANT IL-9 ANTIBODIES AND USES THEREOF

#60 | 2008-12-18

US20080311122A1

Chemistry; metallurgy

Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof

#61 | 2008-07-31

US20080181887A1

Chemistry; metallurgy

Molecules with extended half-lives, compositions and uses thereof

#62 | 2008-06-12

US20080138336A1

Chemistry; metallurgy

Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

#63 | 2008-05-22

US20080118506A1

Chemistry; metallurgy

Humanized anti-factor D antibodies

#64 | 2007-05-17

US20070111260A1

Chemistry; metallurgy

Cell display of antibody libraries

#65 | 2006-11-09

US20060251644A1

Chemistry; metallurgy

High affinity anti-human IgE antibodies

#66 | 2006-10-19

US20060234296A1

Chemistry; metallurgy

Method for generating high affinity antibodies

#67 | 2006-10-12

US20060228350A1

Chemistry; metallurgy

Framework-shuffling of antibodies

#68 | 2006-06-01

US20060115485A1

Chemistry; metallurgy

Methods of preventing and treating RSV infections and related conditions

#69 | 2006-05-11

US20060099207A1

Chemistry; metallurgy

High affinity antibodies against HMGB1 and methods of use thereof

#70 | 2006-05-04

US20060094062A1

Chemistry; metallurgy

Ultra high throughput capture lift screening methods

#71 | 2006-02-23

US20060040325A1

Physics

Integrin antagonists with enhanced antibody dependent cell-mediated cytoxicity activity

#72 | 2006-02-23

US20060039904A1

Physics

Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity

#73 | 2006-01-26

US20060019342A1

Chemistry; metallurgy

Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis

#74 | 2005-09-08

US20050196749A1

Chemistry; metallurgy

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

#75 | 2005-08-18

US20050181479A1

Chemistry; metallurgy

Periplasmic expression of antibodies using a single signal sequence

#76 | 2005-07-07

US20050147616A1

Chemistry; metallurgy

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

#77 | 2005-03-24

US20050064438A1

Chemistry; metallurgy

Heteromeric variable regions with unvaried human framework regions

#78 | 2005-03-03

US20050048617A1

Chemistry; metallurgy

Humanization of antibodies

#79 | 2005-02-24

US20050042664A1

Chemistry; metallurgy

Humanization of antibodies

#80 | 2005-01-06

US20050002934A1

Chemistry; metallurgy

Recombinant IL-9 antibodies

#81 | 2005-01-06

US20050002926A1

Chemistry; metallurgy

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

InventorID:

113610 ⎘